MeSH tree: D27.505.696.422
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that, among currently ...
23 hours ago
0
10
There is no link between the widely used diabetes and obesity medications known as GLP-1 receptor agonists and increased suicidal thoughts, depression or other serious psychiatric harm, based on an integrative review of current ...
Aug 31, 2026
0
9
Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research ...
Aug 24, 2026
0
13
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes using the medications ...
Aug 20, 2026
0
10
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...
Aug 16, 2026
0
9
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and ...
Aug 14, 2026
0
1565
Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than surgery alone in adolescents, according ...
Aug 11, 2026
0
3
New research by UCLA Health has found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.
Aug 4, 2026
0
3
If there's a word that captures both the great promise and the persistent uncertainty of longevity medicine, it's peptides.
Jul 28, 2026
0
11
Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University ...
Jul 27, 2026
0
5
